In this episode, Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines, discusses how PBM practices are opening doors to counterfeit drugs. Safdar explains the connection between under-reimbursement for pharmacies and the rise in counterfeit medications, shedding light on the critical need for policy changes to ensure drug safety.